Trasylol Plaintiffs Fight Bayer For 'Privileged' Docs

Law360, New York (April 20, 2009, 12:00 AM EDT) -- Bayer AG is facing calls by plaintiffs in multidistrict litigation over its blood-clotting drug Trasylol to hand over thousands of documents the pharmaceutical company claims are protected by attorney-client privilege.

In a motion filed in the U.S. District Court for the Southern District of Florida on Friday, the plaintiffs argued that production of the more than 7,000 sought-after documents would help bring the “long-running” pretrial discovery process to a welcome close.

The plaintiffs called on the court to issue a global production order modeled on those...
To view the full article, register now.